A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is 1 874,22 Kč, with a 24-hour trading volume of 58,49M Kč. The asset's market cap is 5,81T Kč, after moving -1.06% in the last day.
Tokenized AstraZeneca PLC is trading at 1 880,85 Kč, with a tokenized market cap of 14,1M Kč and a 24-hour trading volume of 1,4M Kč. The tokenized asset has moved 0.18% in the past 24 hours.